Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 26, 2022
Panoramic Health announced the launch of its clinical research division dedicated to advancing kidney care innovation and improving patient outcomes.
read more
Wednesday, October 26, 2022
QSAM Biosciences, Inc. announced the addition of Rutgers Cancer Institute of New Jersey (RCINJ) as a clinical trial site approved to begin enrolling patients into the Phase 1 study evaluating CycloSam® in treating patients with bone cancer that ...
read more
Paradigm Clinical Research, with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical ...
read more
The PPD clinical research business of Thermo Fisher Scientific Inc. announced the creation of the PPD DCT Network to support global investigators and research sites participating in decentralized clinical trials (DCTs) for pharmaceutical and biotech ...
read more
Thursday, October 06, 2022
ICON plc has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax...
read more
Worldwide Clinical Trials, Inc. expanded its early phase clinical trial capabilities by opening its Bioanalytical Center of Excellence – a larger state-of-the-art lab in Austin, Texas.
read more
Lonza has enhanced its offering for customers in the early phases of their clinical trials by adding a dedicated Early Phase Clinical Manufacturing facility at its Small Molecules site in Bend, Oregon.
read more
Advarra announced the launch of the Advarra Partner Network, a standardized partnership program designed to extend the research capabilities of Advarra customers and facilitate integration across research technology providers.
read more
Kodiak Sciences Inc. and Lonza announced the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp (CH).
read more
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, has entered into an agreement to partner with N-SIDE — a deeptech ...
read more
AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway...
read more
Catalyst Clinical Research, a provider of clinical research services, announced a strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies.
read more
Worldwide Clinical Trials, Inc. a midsize, full-service contract research organization (CRO), announced that Rosemarie Corrigan has joined the company as executive vice president, global quality.
read more
Iterative Scopes, a provider of precision medicine technologies for gastroenterology, has acquired Clinical Research Strategy Group, LLC and Precision Research (CRSG/Precision),
read more
Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management.
read more